Increased levels of the synaptic proteins PSD-95, SNAP-25, and neurogranin in the cerebrospinal fluid of patients with Alzheimer’s disease

BACKGROUND: There is currently a lack of reliable and easily accessible biomarkers predicting cognitive decline in Alzheimer’s disease (AD). Synaptic dysfunction and loss occur early in AD and synaptic loss measured in the brain tissue and by PET are closely linked to cognitive decline, rendering sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Kivisäkk, Pia, Carlyle, Becky C., Sweeney, Thadryan, Quinn, James P., Ramirez, Christopher E., Trombetta, Bianca A., Mendes, Muriel, Brock, Mary, Rubel, Carrie, Czerkowicz, Julie, Graham, Danielle, Arnold, Steven E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9034610/
https://www.ncbi.nlm.nih.gov/pubmed/35461266
http://dx.doi.org/10.1186/s13195-022-01002-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9034610/
https://www.ncbi.nlm.nih.gov/pubmed/35461266
http://dx.doi.org/10.1186/s13195-022-01002-x

Ejemplares similares